These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 21153712)
1. Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 × Brown Norway rats. Carter CS; Giovannini S; Seo DO; DuPree J; Morgan D; Chung HY; Lees H; Daniels M; Hubbard GB; Lee S; Ikeno Y; Foster TC; Buford TW; Marzetti E Age (Dordr); 2011 Jun; 33(2):167-83. PubMed ID: 21153712 [TBL] [Abstract][Full Text] [Related]
2. Late-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle. Marzetti E; Calvani R; DuPree J; Lees HA; Giovannini S; Seo DO; Buford TW; Sweet K; Morgan D; Strehler KY; Diz D; Borst SE; Moningka N; Krotova K; Carter CS Age (Dordr); 2013 Aug; 35(4):1061-75. PubMed ID: 22639176 [TBL] [Abstract][Full Text] [Related]
3. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension. Kalliovalkama J; Kähönen M; Tolvanen JP; Wu X; Voipio J; Pekki A; Doris PA; Ylitalo P; Pörsti I Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney. Kim JM; Heo HS; Choi YJ; Ye BH; Mi Ha Y; Seo AY; Yu BP; Leeuwenburgh C; Chung HY; Carter CS Exp Gerontol; 2011 Jul; 46(7):542-8. PubMed ID: 21377515 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats. Carter CS; Cesari M; Ambrosius WT; Hu N; Diz D; Oden S; Sonntag WE; Pahor M J Gerontol A Biol Sci Med Sci; 2004 May; 59(5):416-23. PubMed ID: 15123750 [TBL] [Abstract][Full Text] [Related]
6. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats. Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063 [TBL] [Abstract][Full Text] [Related]
8. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats. Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466 [TBL] [Abstract][Full Text] [Related]
9. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat. Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107 [TBL] [Abstract][Full Text] [Related]
10. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers. Vervoort G; Hertenberg F; Wetzels JF; Smits P J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153 [TBL] [Abstract][Full Text] [Related]
11. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model. Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221 [TBL] [Abstract][Full Text] [Related]
12. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612 [TBL] [Abstract][Full Text] [Related]
13. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction. Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Makino N; Sugano M; Otsuka S; Hata T Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of late-life initiation of low-dose enalapril and losartan on diastolic function in senescent Fischer 344 x Brown Norway male rats. Groban L; Lindsey S; Wang H; Lin MS; Kassik KA; Machado FS; Carter CS Age (Dordr); 2012 Aug; 34(4):831-43. PubMed ID: 21720770 [TBL] [Abstract][Full Text] [Related]
16. Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats. Dukacz SA; Kline RL J Hypertens; 1999 Sep; 17(9):1345-52. PubMed ID: 10489114 [TBL] [Abstract][Full Text] [Related]
17. Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man. Yee KM; Struthers AD Br J Clin Pharmacol; 1998 Dec; 46(6):583-8. PubMed ID: 9862248 [TBL] [Abstract][Full Text] [Related]
18. Haemodynamic effects of dual blockade of the renin-angiotensin system in spontaneously hypertensive rats: influence of salt. Richer-Giudicelli C; Domergue V; Gonzalez MF; Messadi E; Azizi M; Giudicelli JF; Ménard J J Hypertens; 2004 Mar; 22(3):619-27. PubMed ID: 15076169 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II inhibition attenuates postexercise proteinuria in rats. Gündüz F; Kuru O; Sentürk UK Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614 [TBL] [Abstract][Full Text] [Related]
20. T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans. Petrov VV; Fagard RH; Lijnen PJ J Cardiovasc Pharmacol; 2001 Oct; 38(4):578-83. PubMed ID: 11588528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]